Table of Content

1 Study Coverage
1.1 Oral Anticoagulants Product Introduction
1.2 Market by Type
1.2.1 Global Oral Anticoagulants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Direct Thrombin Inhibitors
1.2.3 Direct Factor Xa Inhibitors
1.3 Market by Application
1.3.1 Global Oral Anticoagulants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Deep Vein Thrombosis (DVT)
1.3.3 Pulmonary Embolism
1.3.4 Acute Coronary Syndrome
1.3.5 Hemodialysis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Anticoagulants Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Anticoagulants Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Anticoagulants Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Anticoagulants Sales by Region
2.4.1 Global Oral Anticoagulants Sales by Region (2017-2022)
2.4.2 Global Sales Oral Anticoagulants by Region (2024-2028)
2.5 Global Oral Anticoagulants Revenue by Region
2.5.1 Global Oral Anticoagulants Revenue by Region (2017-2022)
2.5.2 Global Oral Anticoagulants Revenue by Region (2024-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Anticoagulants Sales by Manufacturers
3.1.1 Global Top Oral Anticoagulants Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Anticoagulants Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Anticoagulants in 2021
3.2 Global Oral Anticoagulants Revenue by Manufacturers
3.2.1 Global Oral Anticoagulants Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Anticoagulants Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Anticoagulants Revenue in 2021
3.3 Global Oral Anticoagulants Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Anticoagulants Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Anticoagulants Sales by Type
4.1.1 Global Oral Anticoagulants Historical Sales by Type (2017-2022)
4.1.2 Global Oral Anticoagulants Forecasted Sales by Type (2024-2028)
4.1.3 Global Oral Anticoagulants Sales Market Share by Type (2017-2028)
4.2 Global Oral Anticoagulants Revenue by Type
4.2.1 Global Oral Anticoagulants Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Anticoagulants Forecasted Revenue by Type (2024-2028)
4.2.3 Global Oral Anticoagulants Revenue Market Share by Type (2017-2028)
4.3 Global Oral Anticoagulants Price by Type
4.3.1 Global Oral Anticoagulants Price by Type (2017-2022)
4.3.2 Global Oral Anticoagulants Price Forecast by Type (2024-2028)
5 Market Size by Application
5.1 Global Oral Anticoagulants Sales by Application
5.1.1 Global Oral Anticoagulants Historical Sales by Application (2017-2022)
5.1.2 Global Oral Anticoagulants Forecasted Sales by Application (2024-2028)
5.1.3 Global Oral Anticoagulants Sales Market Share by Application (2017-2028)
5.2 Global Oral Anticoagulants Revenue by Application
5.2.1 Global Oral Anticoagulants Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Anticoagulants Forecasted Revenue by Application (2024-2028)
5.2.3 Global Oral Anticoagulants Revenue Market Share by Application (2017-2028)
5.3 Global Oral Anticoagulants Price by Application
5.3.1 Global Oral Anticoagulants Price by Application (2017-2022)
5.3.2 Global Oral Anticoagulants Price Forecast by Application (2024-2028)
6 North America
6.1 North America Oral Anticoagulants Market Size by Type
6.1.1 North America Oral Anticoagulants Sales by Type (2017-2028)
6.1.2 North America Oral Anticoagulants Revenue by Type (2017-2028)
6.2 North America Oral Anticoagulants Market Size by Application
6.2.1 North America Oral Anticoagulants Sales by Application (2017-2028)
6.2.2 North America Oral Anticoagulants Revenue by Application (2017-2028)
6.3 North America Oral Anticoagulants Market Size by Country
6.3.1 North America Oral Anticoagulants Sales by Country (2017-2028)
6.3.2 North America Oral Anticoagulants Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oral Anticoagulants Market Size by Type
7.1.1 Europe Oral Anticoagulants Sales by Type (2017-2028)
7.1.2 Europe Oral Anticoagulants Revenue by Type (2017-2028)
7.2 Europe Oral Anticoagulants Market Size by Application
7.2.1 Europe Oral Anticoagulants Sales by Application (2017-2028)
7.2.2 Europe Oral Anticoagulants Revenue by Application (2017-2028)
7.3 Europe Oral Anticoagulants Market Size by Country
7.3.1 Europe Oral Anticoagulants Sales by Country (2017-2028)
7.3.2 Europe Oral Anticoagulants Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Anticoagulants Market Size by Type
8.1.1 Asia Pacific Oral Anticoagulants Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Anticoagulants Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Anticoagulants Market Size by Application
8.2.1 Asia Pacific Oral Anticoagulants Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Anticoagulants Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Anticoagulants Market Size by Region
8.3.1 Asia Pacific Oral Anticoagulants Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Anticoagulants Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oral Anticoagulants Market Size by Type
9.1.1 Latin America Oral Anticoagulants Sales by Type (2017-2028)
9.1.2 Latin America Oral Anticoagulants Revenue by Type (2017-2028)
9.2 Latin America Oral Anticoagulants Market Size by Application
9.2.1 Latin America Oral Anticoagulants Sales by Application (2017-2028)
9.2.2 Latin America Oral Anticoagulants Revenue by Application (2017-2028)
9.3 Latin America Oral Anticoagulants Market Size by Country
9.3.1 Latin America Oral Anticoagulants Sales by Country (2017-2028)
9.3.2 Latin America Oral Anticoagulants Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Anticoagulants Market Size by Type
10.1.1 Middle East and Africa Oral Anticoagulants Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Anticoagulants Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Anticoagulants Market Size by Application
10.2.1 Middle East and Africa Oral Anticoagulants Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Anticoagulants Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Anticoagulants Market Size by Country
10.3.1 Middle East and Africa Oral Anticoagulants Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Anticoagulants Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Overview
11.2.3 Bristol-Myers Squibb Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bristol-Myers Squibb Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Corporation Information
11.5.2 Daiichi Sankyo Overview
11.5.3 Daiichi Sankyo Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Daiichi Sankyo Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Daiichi Sankyo Recent Developments
11.6 Armatheon
11.6.1 Armatheon Corporation Information
11.6.2 Armatheon Overview
11.6.3 Armatheon Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Armatheon Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Armatheon Recent Developments
11.7 Aspen
11.7.1 Aspen Corporation Information
11.7.2 Aspen Overview
11.7.3 Aspen Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Aspen Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aspen Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AstraZeneca Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca Recent Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Overview
11.9.3 Bayer Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Bayer Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bayer Recent Developments
11.10 Cellceutix
11.10.1 Cellceutix Corporation Information
11.10.2 Cellceutix Overview
11.10.3 Cellceutix Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Cellceutix Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Cellceutix Recent Developments
11.11 Cosmo Pharmaceuticals
11.11.1 Cosmo Pharmaceuticals Corporation Information
11.11.2 Cosmo Pharmaceuticals Overview
11.11.3 Cosmo Pharmaceuticals Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Cosmo Pharmaceuticals Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Cosmo Pharmaceuticals Recent Developments
11.12 CSL Behring
11.12.1 CSL Behring Corporation Information
11.12.2 CSL Behring Overview
11.12.3 CSL Behring Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 CSL Behring Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 CSL Behring Recent Developments
11.13 Eisai
11.13.1 Eisai Corporation Information
11.13.2 Eisai Overview
11.13.3 Eisai Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Eisai Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Eisai Recent Developments
11.14 GSK
11.14.1 GSK Corporation Information
11.14.2 GSK Overview
11.14.3 GSK Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 GSK Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 GSK Recent Developments
11.15 Marathon Pharmaceuticals
11.15.1 Marathon Pharmaceuticals Corporation Information
11.15.2 Marathon Pharmaceuticals Overview
11.15.3 Marathon Pharmaceuticals Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Marathon Pharmaceuticals Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Marathon Pharmaceuticals Recent Developments
11.16 Ockham Biotech
11.16.1 Ockham Biotech Corporation Information
11.16.2 Ockham Biotech Overview
11.16.3 Ockham Biotech Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Ockham Biotech Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Ockham Biotech Recent Developments
11.17 Perosphere
11.17.1 Perosphere Corporation Information
11.17.2 Perosphere Overview
11.17.3 Perosphere Oral Anticoagulants Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Perosphere Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Perosphere Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Anticoagulants Industry Chain Analysis
12.2 Oral Anticoagulants Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Anticoagulants Production Mode & Process
12.4 Oral Anticoagulants Sales and Marketing
12.4.1 Oral Anticoagulants Sales Channels
12.4.2 Oral Anticoagulants Distributors
12.5 Oral Anticoagulants Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Anticoagulants Industry Trends
13.2 Oral Anticoagulants Market Drivers
13.3 Oral Anticoagulants Market Challenges
13.4 Oral Anticoagulants Market Restraints
14 Key Findings in The Global Oral Anticoagulants Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oral Anticoagulants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Direct Thrombin Inhibitors
Table 3. Major Manufacturers of Direct Factor Xa Inhibitors
Table 4. Global Oral Anticoagulants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Oral Anticoagulants Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Oral Anticoagulants Sales by Region (2017-2022) & (K Units)
Table 7. Global Oral Anticoagulants Sales Market Share by Region (2017-2022)
Table 8. Global Oral Anticoagulants Sales by Region (2024-2028) & (K Units)
Table 9. Global Oral Anticoagulants Sales Market Share by Region (2024-2028)
Table 10. Global Oral Anticoagulants Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Oral Anticoagulants Revenue Market Share by Region (2017-2022)
Table 12. Global Oral Anticoagulants Revenue by Region (2024-2028) & (US$ Million)
Table 13. Global Oral Anticoagulants Revenue Market Share by Region (2024-2028)
Table 14. Global Oral Anticoagulants Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Oral Anticoagulants Sales Share by Manufacturers (2017-2022)
Table 16. Global Oral Anticoagulants Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Oral Anticoagulants Revenue Share by Manufacturers (2017-2022)
Table 18. Oral Anticoagulants Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Oral Anticoagulants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Oral Anticoagulants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anticoagulants as of 2021)
Table 21. Oral Anticoagulants Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Oral Anticoagulants Product Offered
Table 23. Date of Manufacturers Enter into Oral Anticoagulants Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 26. Global Oral Anticoagulants Sales by Type (2024-2028) & (K Units)
Table 27. Global Oral Anticoagulants Sales Share by Type (2017-2022)
Table 28. Global Oral Anticoagulants Sales Share by Type (2024-2028)
Table 29. Global Oral Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Oral Anticoagulants Revenue by Type (2024-2028) & (US$ Million)
Table 31. Global Oral Anticoagulants Revenue Share by Type (2017-2022)
Table 32. Global Oral Anticoagulants Revenue Share by Type (2024-2028)
Table 33. Oral Anticoagulants Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Oral Anticoagulants Price Forecast by Type (2024-2028) & (USD/Unit)
Table 35. Global Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 36. Global Oral Anticoagulants Sales by Application (2024-2028) & (K Units)
Table 37. Global Oral Anticoagulants Sales Share by Application (2017-2022)
Table 38. Global Oral Anticoagulants Sales Share by Application (2024-2028)
Table 39. Global Oral Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Oral Anticoagulants Revenue by Application (2024-2028) & (US$ Million)
Table 41. Global Oral Anticoagulants Revenue Share by Application (2017-2022)
Table 42. Global Oral Anticoagulants Revenue Share by Application (2024-2028)
Table 43. Oral Anticoagulants Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Oral Anticoagulants Price Forecast by Application (2024-2028) & (USD/Unit)
Table 45. North America Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 46. North America Oral Anticoagulants Sales by Type (2024-2028) & (K Units)
Table 47. North America Oral Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Oral Anticoagulants Revenue by Type (2024-2028) & (US$ Million)
Table 49. North America Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 50. North America Oral Anticoagulants Sales by Application (2024-2028) & (K Units)
Table 51. North America Oral Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Oral Anticoagulants Revenue by Application (2024-2028) & (US$ Million)
Table 53. North America Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 54. North America Oral Anticoagulants Sales by Country (2024-2028) & (K Units)
Table 55. North America Oral Anticoagulants Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Oral Anticoagulants Revenue by Country (2024-2028) & (US$ Million)
Table 57. Europe Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 58. Europe Oral Anticoagulants Sales by Type (2024-2028) & (K Units)
Table 59. Europe Oral Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Oral Anticoagulants Revenue by Type (2024-2028) & (US$ Million)
Table 61. Europe Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 62. Europe Oral Anticoagulants Sales by Application (2024-2028) & (K Units)
Table 63. Europe Oral Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Oral Anticoagulants Revenue by Application (2024-2028) & (US$ Million)
Table 65. Europe Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 66. Europe Oral Anticoagulants Sales by Country (2024-2028) & (K Units)
Table 67. Europe Oral Anticoagulants Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Oral Anticoagulants Revenue by Country (2024-2028) & (US$ Million)
Table 69. Asia Pacific Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Oral Anticoagulants Sales by Type (2024-2028) & (K Units)
Table 71. Asia Pacific Oral Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Oral Anticoagulants Revenue by Type (2024-2028) & (US$ Million)
Table 73. Asia Pacific Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Oral Anticoagulants Sales by Application (2024-2028) & (K Units)
Table 75. Asia Pacific Oral Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Oral Anticoagulants Revenue by Application (2024-2028) & (US$ Million)
Table 77. Asia Pacific Oral Anticoagulants Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Oral Anticoagulants Sales by Region (2024-2028) & (K Units)
Table 79. Asia Pacific Oral Anticoagulants Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Oral Anticoagulants Revenue by Region (2024-2028) & (US$ Million)
Table 81. Latin America Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Oral Anticoagulants Sales by Type (2024-2028) & (K Units)
Table 83. Latin America Oral Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Oral Anticoagulants Revenue by Type (2024-2028) & (US$ Million)
Table 85. Latin America Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Oral Anticoagulants Sales by Application (2024-2028) & (K Units)
Table 87. Latin America Oral Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Oral Anticoagulants Revenue by Application (2024-2028) & (US$ Million)
Table 89. Latin America Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Oral Anticoagulants Sales by Country (2024-2028) & (K Units)
Table 91. Latin America Oral Anticoagulants Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Oral Anticoagulants Revenue by Country (2024-2028) & (US$ Million)
Table 93. Middle East and Africa Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Oral Anticoagulants Sales by Type (2024-2028) & (K Units)
Table 95. Middle East and Africa Oral Anticoagulants Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Oral Anticoagulants Revenue by Type (2024-2028) & (US$ Million)
Table 97. Middle East and Africa Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Oral Anticoagulants Sales by Application (2024-2028) & (K Units)
Table 99. Middle East and Africa Oral Anticoagulants Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Oral Anticoagulants Revenue by Application (2024-2028) & (US$ Million)
Table 101. Middle East and Africa Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Oral Anticoagulants Sales by Country (2024-2028) & (K Units)
Table 103. Middle East and Africa Oral Anticoagulants Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Oral Anticoagulants Revenue by Country (2024-2028) & (US$ Million)
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Major Businesses
Table 107. Johnson & Johnson Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Johnson & Johnson Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Johnson & Johnson Recent Developments
Table 110. Bristol-Myers Squibb Corporation Information
Table 111. Bristol-Myers Squibb Description and Major Businesses
Table 112. Bristol-Myers Squibb Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Bristol-Myers Squibb Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bristol-Myers Squibb Recent Developments
Table 115. Boehringer Ingelheim Corporation Information
Table 116. Boehringer Ingelheim Description and Major Businesses
Table 117. Boehringer Ingelheim Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Boehringer Ingelheim Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Boehringer Ingelheim Recent Developments
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Major Businesses
Table 122. Sanofi Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Sanofi Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sanofi Recent Developments
Table 125. Daiichi Sankyo Corporation Information
Table 126. Daiichi Sankyo Description and Major Businesses
Table 127. Daiichi Sankyo Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Daiichi Sankyo Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Daiichi Sankyo Recent Developments
Table 130. Armatheon Corporation Information
Table 131. Armatheon Description and Major Businesses
Table 132. Armatheon Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Armatheon Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Armatheon Recent Developments
Table 135. Aspen Corporation Information
Table 136. Aspen Description and Major Businesses
Table 137. Aspen Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Aspen Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Aspen Recent Developments
Table 140. AstraZeneca Corporation Information
Table 141. AstraZeneca Description and Major Businesses
Table 142. AstraZeneca Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. AstraZeneca Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. AstraZeneca Recent Developments
Table 145. Bayer Corporation Information
Table 146. Bayer Description and Major Businesses
Table 147. Bayer Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Bayer Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Bayer Recent Developments
Table 150. Cellceutix Corporation Information
Table 151. Cellceutix Description and Major Businesses
Table 152. Cellceutix Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Cellceutix Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Cellceutix Recent Developments
Table 155. Cosmo Pharmaceuticals Corporation Information
Table 156. Cosmo Pharmaceuticals Description and Major Businesses
Table 157. Cosmo Pharmaceuticals Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 158. Cosmo Pharmaceuticals Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Cosmo Pharmaceuticals Recent Developments
Table 160. CSL Behring Corporation Information
Table 161. CSL Behring Description and Major Businesses
Table 162. CSL Behring Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 163. CSL Behring Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. CSL Behring Recent Developments
Table 165. Eisai Corporation Information
Table 166. Eisai Description and Major Businesses
Table 167. Eisai Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 168. Eisai Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Eisai Recent Developments
Table 170. GSK Corporation Information
Table 171. GSK Description and Major Businesses
Table 172. GSK Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 173. GSK Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. GSK Recent Developments
Table 175. Marathon Pharmaceuticals Corporation Information
Table 176. Marathon Pharmaceuticals Description and Major Businesses
Table 177. Marathon Pharmaceuticals Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 178. Marathon Pharmaceuticals Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Marathon Pharmaceuticals Recent Developments
Table 180. Ockham Biotech Corporation Information
Table 181. Ockham Biotech Description and Major Businesses
Table 182. Ockham Biotech Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 183. Ockham Biotech Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Ockham Biotech Recent Developments
Table 185. Perosphere Corporation Information
Table 186. Perosphere Description and Major Businesses
Table 187. Perosphere Oral Anticoagulants Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 188. Perosphere Oral Anticoagulants Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Perosphere Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Oral Anticoagulants Distributors List
Table 193. Oral Anticoagulants Customers List
Table 194. Oral Anticoagulants Market Trends
Table 195. Oral Anticoagulants Market Drivers
Table 196. Oral Anticoagulants Market Challenges
Table 197. Oral Anticoagulants Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Anticoagulants Product Picture
Figure 2. Global Oral Anticoagulants Market Share by Type in 2021 & 2028
Figure 3. Direct Thrombin Inhibitors Product Picture
Figure 4. Direct Factor Xa Inhibitors Product Picture
Figure 5. Global Oral Anticoagulants Market Share by Application in 2021 & 2028
Figure 6. Deep Vein Thrombosis (DVT)
Figure 7. Pulmonary Embolism
Figure 8. Acute Coronary Syndrome
Figure 9. Hemodialysis
Figure 10. Others
Figure 11. Oral Anticoagulants Report Years Considered
Figure 12. Global Oral Anticoagulants Sales 2017-2028 (K Units)
Figure 13. Global Oral Anticoagulants Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Oral Anticoagulants Revenue 2017-2028 (US$ Million)
Figure 15. Global Oral Anticoagulants Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Oral Anticoagulants Sales Market Share by Region (2017-2022)
Figure 17. Global Oral Anticoagulants Sales Market Share by Region (2024-2028)
Figure 18. North America Oral Anticoagulants Sales YoY (2017-2028) & (K Units)
Figure 19. North America Oral Anticoagulants Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Oral Anticoagulants Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Oral Anticoagulants Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Oral Anticoagulants Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Oral Anticoagulants Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Oral Anticoagulants Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Oral Anticoagulants Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Oral Anticoagulants Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Oral Anticoagulants Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Oral Anticoagulants Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Oral Anticoagulants in the World: Market Share by Oral Anticoagulants Revenue in 2021
Figure 30. Global Oral Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 32. Global Oral Anticoagulants Revenue Market Share by Type (2017-2028)
Figure 33. Global Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 34. Global Oral Anticoagulants Revenue Market Share by Application (2017-2028)
Figure 35. North America Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 36. North America Oral Anticoagulants Revenue Market Share by Type (2017-2028)
Figure 37. North America Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 38. North America Oral Anticoagulants Revenue Market Share by Application (2017-2028)
Figure 39. North America Oral Anticoagulants Sales Share by Country (2017-2028)
Figure 40. North America Oral Anticoagulants Revenue Share by Country (2017-2028)
Figure 41. U.S. Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 44. Europe Oral Anticoagulants Revenue Market Share by Type (2017-2028)
Figure 45. Europe Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 46. Europe Oral Anticoagulants Revenue Market Share by Application (2017-2028)
Figure 47. Europe Oral Anticoagulants Sales Share by Country (2017-2028)
Figure 48. Europe Oral Anticoagulants Revenue Share by Country (2017-2028)
Figure 49. Germany Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 50. France Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Oral Anticoagulants Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Oral Anticoagulants Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Oral Anticoagulants Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Oral Anticoagulants Revenue Share by Region (2017-2028)
Figure 60. China Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 63. India Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 71. Latin America Oral Anticoagulants Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 73. Latin America Oral Anticoagulants Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Oral Anticoagulants Sales Share by Country (2017-2028)
Figure 75. Latin America Oral Anticoagulants Revenue Share by Country (2017-2028)
Figure 76. Mexico Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Oral Anticoagulants Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Oral Anticoagulants Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Oral Anticoagulants Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Oral Anticoagulants Revenue Share by Country (2017-2028)
Figure 85. Turkey Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Oral Anticoagulants Revenue (2017-2028) & (US$ Million)
Figure 88. Oral Anticoagulants Value Chain
Figure 89. Oral Anticoagulants Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed